secwatch.observer — SEC 8-K summary
======================================

Issuer:     BOSTON SCIENTIFIC CORP (BSX)
CIK:        0000885725
Form:       8-K
Filed at:   2023-11-22T23:59:59+00:00
Accession:  0000885725-23-000051
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Two Boston Scientific directors not standing for re-election in 2024
--------------------------------------------------------------------

- Nelda J. Connors, director since 2009 and Risk Committee chair, will not seek re-election at 2024 annual meeting.
- David J. Roux, director since 2014 and Audit / Nominating & Governance committee member, also departing.
- Both departures are not due to any disagreement with the company.
- Board to evaluate adding new directors to fill upcoming vacancies.
- Also approved 2024 Annual Bonus Plan and new performance share programs for executives.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/885725/000088572523000051/0000885725-23-000051-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/885725/000088572523000051/bsx-20231116.htm
  HTML page:      https://secwatch.observer/filing/0000885725-23-000051

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer